drugset / Trial / NCT01242332

Perioperative Administration of Pregabalin in Patients Undergoing Arthroscopic Anterior Cruciate Ligament Reconstruction

NCT01242332

Phase 4 Completed 60 enrolled Prince of Songkla University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To prove pregabalin's efficacy and safety in Thai patients scheduled for arthroscopic ACL reconstruction

Timeline

Start
2009-08
Primary completion
2010-10
Completion
2010-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule 75 mg Oral

Indications

No indication recorded.